Table 1.
Results of recent trials for flow diversion
| Device | Patients (aneurysms) (n) | Successful deployment (%) | ICH (%) | Mortality (%) | Periprocedural complications (%) | Delayed aneurysm occlusion |
|---|---|---|---|---|---|---|
| PED [11] | 905 (1043) | 99 | 2.3 | 2.3 | 5.6 | 80 % at 6 months |
| SILK [21, 22] | 92 (103) | 96 | 4.3 | 4.3 | 10.9 | 79.2 at 12 months |
| Surpass [23, 24] | 165 (190) | 98 | 6.2 | 2.7 | 11.4 | 75 % at 6 months |
| FRED [25] | 29 (34) | 100 | 0 | 0 | 13.8 | 73 % at 6 months |
| p64 [26, 27] | 121(130) | 97 | 0 | 0.8 | 2.3 | 87.7 % at 9 months |
ICH = intracranial hemorrhage; PED = pipeline embolization device; FRED = flow redirection endoluminal device system